Canada Medical Cannabis Market, by Route of Administration

Growth Outlook

• The Canada Medical Cannabis Market, by Route of Administration market is on a steady long-term growth path. Segment value stands at roughly USD 3553 Mn in 2026 and is projected to reach USD 3912 Mn by 2027 — a gain of about 10% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Inhalation leads, holding roughly 59% of segment value — the single largest regional share. Oral is the second-largest contributor. Topical make up the remainder, in descending order.
• By 2027, Inhalation alone is expected to reach USD 2306 Mn, with Oral at USD 1068 Mn.

Market Dynamics

The demand for medical cannabis in Canada has been steadily increasing, as more and more patients and healthcare professionals realize the potential benefits of this alternative form of medication. While the market size and growth rates may be important factors to consider, it is equally important to examine the demand for medical cannabis by route of administration.

One of the most common routes of administration of medical cannabis is through smoking or vaporizing the plant. This method allows for quick and direct absorption of the active compounds in the cannabis, providing patients with fast relief from symptoms such as pain, nausea, and anxiety. However, concerns over long-term lung health and potential risks associated with smoking have led to a growing demand for alternative routes of administration.

Oral ingestion, in the form of capsules or edibles, has been gaining popularity among medical cannabis patients. This method offers a more discreet and convenient way of consuming cannabis, as well as a longer-lasting effect. When ingested, cannabis is metabolized by the liver, resulting in a different set of therapeutic effects compared to smoking. This route of administration is particularly beneficial for patients seeking long-term pain relief or for those who cannot or choose not to inhale cannabis.

Topical application of medical cannabis has also been on the rise in Canada. This method involves applying cannabis-infused creams, salves, or oils directly onto the skin, providing localized relief for conditions such as arthritis, eczema, or muscle pain. Topical application also avoids the psychoactive effects associated with other routes of administration, making it a popular choice for patients who want to avoid feeling “high.”

Another emerging route of administration for medical cannabis is through sublingual and buccal administration. This involves placing cannabis oils or tinctures under the tongue or between the cheek and gum, allowing for quick and efficient absorption through the mucous membranes. This method is particularly useful for patients who cannot or prefer not to smoke or ingest cannabis.

In conclusion, while the overall demand for medical cannabis in Canada is undoubtedly on the rise, it is important to consider the different routes of administration that are available. Each method offers unique benefits and can cater to the diverse needs of medical cannabis patients. As more research is conducted and new products are introduced, the demand for medical cannabis by route of administration is only expected to continue to grow.